|
CA2343840C
(en)
*
|
1998-10-20 |
2011-03-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of a cytokine-producing lactococcus strain to treat colitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
ES2381775T3
(es)
|
2000-08-04 |
2012-05-31 |
Dmi Biosciences, Inc. |
Procedimiento del uso de dicetopiperazinas y composición que las contiene
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
US7575929B2
(en)
*
|
2002-10-02 |
2009-08-18 |
Dmi Life Sciences, Inc. |
Diagnosis of multiple sclerosis with diketopiperazines
|
|
AU2003298291A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
CN101947306B
(zh)
|
2003-05-15 |
2014-06-18 |
安皮奥制药股份有限公司 |
T-细胞介导的疾病的治疗
|
|
GB2422373B
(en)
|
2003-08-18 |
2008-05-21 |
Btg Int Ltd |
Treatment of neurodegenerative conditions
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
WO2005073164A1
(en)
*
|
2004-01-30 |
2005-08-11 |
Peplin Biolipids Pty Ltd |
Therapeutic and carrier molecules
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
US8748126B2
(en)
|
2005-11-29 |
2014-06-10 |
Actogenix N.V. |
Induction of mucosal tolerance to antigens
|
|
EP2125010B1
(en)
|
2007-01-25 |
2014-06-04 |
Actogenix N.V. |
Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
|
|
EP2120916A4
(en)
*
|
2007-02-05 |
2010-07-28 |
Children Youth And Women S Hea |
MODULATORS FOR THE PROLIFERATION OF T CELLS DEPENDENT OF ANTIGEN
|
|
ES2733353T3
(es)
|
2007-11-09 |
2019-11-28 |
Basf As |
Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
|
|
JP5856843B2
(ja)
*
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
CN102459142B
(zh)
|
2009-05-08 |
2017-08-08 |
普罗诺瓦生物医药挪威公司 |
用于治疗与心血管、代谢和炎性疾病领域相关的疾病的多不饱和脂肪酸
|
|
GB0909643D0
(en)
*
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
*
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
US8507496B2
(en)
|
2010-09-07 |
2013-08-13 |
Dmi Acquisition Corp. |
Treatment of diseases
|
|
SG10201509127YA
(en)
|
2010-11-05 |
2015-12-30 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
KR102032400B1
(ko)
|
2011-10-10 |
2019-10-15 |
앰피오 파마슈티컬스 인코퍼레이티드 |
퇴행성 관절 질환의 치료
|
|
EP2765968A4
(en)
|
2011-10-10 |
2015-01-21 |
Ampio Pharmaceuticals Inc |
IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
|
|
SG10201605205VA
(en)
|
2011-10-28 |
2016-08-30 |
Ampio Pharmaceuticals Inc |
Treatment of rhinitis
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
BR122020006518B1
(pt)
|
2012-03-30 |
2022-02-22 |
Givaudan Sa |
Composição de sabor
|
|
SG11201405413SA
(en)
|
2012-03-30 |
2014-10-30 |
Givaudan Sa |
N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
|
|
EP2833738B1
(en)
|
2012-03-30 |
2019-10-30 |
Givaudan S.A. |
N-acylated methionine derivatives as food flavouring compounds
|
|
WO2013149031A2
(en)
|
2012-03-30 |
2013-10-03 |
Givaudan S.A. |
Powder flavour composition
|
|
US10711230B2
(en)
|
2012-03-30 |
2020-07-14 |
Givaudan Sa |
N-acyl proline derivatives as food flavoring compounds
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
BR112014024323B1
(pt)
|
2012-03-30 |
2020-03-10 |
Givaudan Sa |
Composições compreendendo ácidos 1-aminocicloalquil carboxílicos n-acilados, solução padrão e uso
|
|
JP6224072B2
(ja)
|
2012-03-30 |
2017-11-01 |
ジボダン エス エー |
フレーバープロフィール食用組成物の改良のためのｎ−アシル−アミノ酸誘導体
|
|
GB201221329D0
(en)
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
ES2748562T3
(es)
|
2013-02-28 |
2020-03-17 |
Basf As |
Una composición que comprende un compuesto lipídico, un triglicérido y un tensioactivo, y procedimientos de uso de la misma
|
|
KR20150132508A
(ko)
|
2013-03-15 |
2015-11-25 |
앰피오 파마슈티컬스 인코퍼레이티드 |
줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
|
|
US10537127B2
(en)
|
2013-10-02 |
2020-01-21 |
Givaudan S.A. |
Organic compounds
|
|
EP3052472B1
(en)
|
2013-10-02 |
2019-02-27 |
Givaudan S.A. |
N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
|
|
EP3057444B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan SA |
Organic compounds having taste-modifying properties
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
EP3057447B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
WO2015050534A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
EP4066836A1
(en)
|
2014-08-18 |
2022-10-05 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
CN107530306A
(zh)
|
2015-04-28 |
2018-01-02 |
普罗诺瓦生物医药挪威公司 |
结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途
|
|
EP3310375A4
(en)
|
2015-06-22 |
2019-02-20 |
Ampio Pharmaceuticals, Inc. |
USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
|
|
WO2017156164A1
(en)
|
2016-03-09 |
2017-09-14 |
Board Of Regents, The University Of Texas System |
20-hete receptor (gpr75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
KR20190055153A
(ko)
|
2016-09-21 |
2019-05-22 |
아벡신 에이에스 |
약학 조성물
|
|
IL275002B2
(en)
|
2017-12-06 |
2024-04-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|